Multiple Endocrine Neoplasia Type 2A — Trials

Multiple Endocrine Neoplasia Type 2A — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01793168	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford(CoRDS)	recruiting	—	20,000	Sanford HealthOTHER	2	May 29, 2025	clinicaltrials
NCT00390325	Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer	completed	Phase 2	21	National Cancer Institute (NCI)NIH	1	Feb 6, 2024	clinicaltrials
NCT00514046	Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer	completed	Phase 1 / Phase 2	17	National Cancer Institute (NCI)NIH	1	Dec 22, 2020	clinicaltrials
NCT02831179	Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor	withdrawn	Phase 1	0	Vanderbilt-Ingram Cancer Center

Data updated 22 days agoSource updated May 29, 2025source: clinicaltrials